Recipharm Annual Report 2006

More documents

Recommendations

Info

PARENT COMPANY INCOME STATEMENTS Note 1 Jan 2006 31 Dec 2006 1 Jan 2005 31 Dec 2005 Operating income, etc. Net sales 1 135,506,635 254,422,035 Other operating income 6,000,270 3,724,343 141,506,905 258,146,378 Operating expenses 1 Raw materials and consumables -66,614,327 -72,932,611 Other external expenses 2, 3 -73,989,849 -92,640,276 Personnel costs 4 -78,733,178 -106,173,966 Depreciation of tangible and amortisation of Intangible non-current assets 7,8,9,10,11 -23,192,909 -11,610,278 Loss on disposal of tangible fixed assets -456,316 0 Other operating expenses 5 -5,130,194 -1,636,867 -248,116,773 -284,993,998 Operating profit/loss -106,609,868 -26,847,620 Result from financial items Result from participations in Group companies -38,000,000 574,900,000 Other interest income and similar profit/loss items 758,535 195,087 Other interest income from Group companies 2,034,956 826,432 Interest expenses and similar profit/loss items -4,817,410 -2,752,915 Interest expenses to Group companies 0 -612,669 -40,023,919 572,555,935 Profit/loss after financial items -146,633,787 545,708,315 Appropriations Transfer to tax allocation reserve 0 -7,900,000 Reversal from tax allocation reserve 2,804,299 4,651,946 Change of accelerated depreciation -4,051 , 647. -5,256,596 -1,247,348 -8,504,650 Profit/loss before taxes -147,881,135 537,203,665 Tax on profit for the year 6 29,851,338 9,554,257 Net profit/loss for the year -118,029,797 546,757,922
PARENT COMPANY BALANCE SHEETS ASSETS Fixed assets Note 31 Dec 2006 31 Dec 2005 Intangible fixed assets Product rights 7 71,722,884 71,713,758 Other intangible fixed assets 8 5,593,633 7,872,950 77,316,517 79,586,708 Tangible fixed assets Land and buildings 9 914,507 954,046 Improvement expenses for other parties’ property 10 334,998 370,844 Machinery and equipment 11 8,426,277 9,306,273 9,675,782 10,631,163 Financial fixed assets Participations in Group companies 13 579,755,545 579,632,620 Receivables from Group companies 14 223,000,000 0 Other investments held as fixed assets 154,710 92,980 Other long-term receivables 15 0 6,321,115 802,910,255 586,046,715 Total fixed assets 889,902,554 676,264,586 Current assets Inventories Finished products and goods for resale 6,834,201 3,254,687 6,834,201 3,254,687 Current receivables Accounts receivable - trade 15,807,566 13,229,441 Receivables from Group companies 157,530,476 246,671,319 Income taxes recoverable 39,246,746 3,538,411 Other receivables 5,654,944 20,208,076 Prepaid expenses and accrued income 17 5,068,364 3,871,586 223,308,096 287,518,833 Cash and bank balances 18 48,289,841 16,483,250 Total current assets 278,432,138 307,256,770 TOTAL ASSETS 168,334,692 983,521,356
Page 1 and 2: ANNUAL REPORT AND CONSOLIDATED ACCO
Page 3 and 4: the form of powders and granulates,
Page 5 and 6: Research and development Recip’s
Page 7 and 8: Investments Gross investments for t
Page 9 and 10: CONSOLIDATED BALANCE SHEETS ASSETS
Page 11: CONSOLIDATED CASH FLOW STATEMENTS 1
Page 15 and 16: PARENT COMPANY CASH FLOW ANALYSES O
Page 17 and 18: Depreciation/amortisation principle
Page 19 and 20: Note 3 Fees and remuneration for au
Page 21 and 22: The Norwegian branch stands for SEK
Page 23 and 24: PARENT COMPANY 31 Dec 2006 31 Dec 2
Page 25 and 26: Acquisition value via transfer of a
Page 27 and 28: Closing accumulated acquisition cos
Page 29 and 30: Repayments of borrowings within 5 y
Page 31 and 32: Stockholm, 22 March 2007 Anders G C

Recipharm Annual Report 2006

Create successful ePaper yourself

Delete template?

Save as template?